Children's Hospital of Wisconsin logo   spacing image
About Children's Hospital and Health Systemspacing image
Quick Links for:
spacing imageParents & FamiliesDonors & VolunteersHealth Care Professionalsspacing image
    Search:
                          
Horizontal stripes
spacing imageHomeHealth InformationFind a DoctorMaps & DirectionsGiving & VolunteeringNews & CalendarResearchCommunity ProgramsGift ShopCareersspacing image
Children's Research Institute Logo
spacing image
  Overview
 
  For Researchers and Staff
 
 
Side navigation, highlighted area, top left Side navigation, highlighted area, top center Side navigation, highlighted area, top right
  Investigators at CRI
 
Side navigation, highlighted area, bottom left Side navigation, highlighted area, bottom center Side navigation, highlighted area, bottom right
 
  Translational Research Programs
 
  Newsletters
 
  Current research at CRI
 
  Newsroom
 
  Events
 
  Support CRI
 
spacing image
spacing image spacing image E-mail this page E-mail this page     Print this page Print this page
spacing image spacing image

Ramin Alemzadeh, MD

Diabetes and Endocrinology             

Ramin Alemzadeh, MDTitle(s): Program director, Diabetes, Children's Hospital of Wisconsin; professor, Medical College of Wisconsin.

Education: Medical degree, St. George's University, School of Medicine, Grenada, West Indies, 1982; internship, Surgery and OB/GYN, North Middlesex Hospital, London, UK, 1982-1983; residency, Pediatrics, Newark Beth Israel Medical Center, Newark, N.J., 1985-1988; fellowship, Pediatric Endocrinology, Metabolism & Nutrition, North Shore University Hospital-Cornell University Medical College, Manhasset, N.Y., 1988-1991.                

Certification(s): Pediatrics, Pediatric Endocrinology.

Honors: American Medical Association.

Research interests: Diabetes, obesity, insulin resistance, hyperlipidemia, hypoglycemia, insulin pump therapy, diabetic nephropathy and metabolic bone disease.

Representative publications:

  • Alemzadeh R, Ellis JN, Holzum MK, Parton EA, Wyatt DT. Beneficial Effects of Continuous Subcutaneous Insulin Infusion (CSII and Flexible Multiple Daily Insulin (FMDI) Regimen Using Insulin Glargine in Type 1 Diabetes Mellitus. Pediatrics 2004; 114: e91-e95. URL: www.pediatrics.org/cgi/content/full/114/1/e91. 
  • Alemzadeh R, Fledelius C, Bodvarsdottir T, Sturis J. Attenuation of Hyperinsulinemia by NN414, a SUR1/Kir6.2 Selective K+ATP Channel Opener, Improves Glucose Tolerance and Lipid Profile in Obese Zucker Rats. Metabolism 53(4): 441-447, 2004. 
  • Alemzadeh R, Tushausn K. Modulation of Adipoinsular Axis in Prediabetic ZDF Rats by Diazoxide. Endocrinology 145: 5476-5484, 2004.   
  • Alemzadeh R, Palma-Sisto P, Holzum MK, Parton E. Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Dose of Insulin (MDI) Regimen Display Similar Patterns of Blood Glucose Excursions in Pediatric Type 1 Diabetes (DM). Diabetes Technology and Therapeutics 2005; 7 (4): 587-596.
  • Battaglia MR, Alemzadeh R, Katte H, Hall PL, Perlmuter LC. Brief Report: Disordered Eating and Psychosocial Factors in Female Adolescents with Type 1 Diabetes Mellitus. Journal of Pediatric Psychology 2005. doi:10.1093/jpepsy/jsj047
  • Alemzadeh R, Berhe T, Wyatt DT. Feasibility of Flexible Insulin Therapy with Glargine in Pre-School Children with Type 1 Diabetes Mellitus. Pediatrics 115(5): 1320-1324, 2005.  
  • Alemzadeh R, Lifshitz F. Childhood Obesity. Pediatric Endocrinology, 5th edition, Ed. Lifshits F, Marcel Dekker, Inc., New York, 2006.
  • Alemzadeh, R, Wyatt DT. Diabetes Mellitus. Nelson Text Book of Pediatrics, 18th edition, Eds. Behrman, Kliegman, Jensen, WB Saunders, Philadelphia, Pa., 2006.

Current grants:

  • Use of (Glycosylated Hemoglobin), Pediatric Growth Parameters, Maternal Prenatal Health History and Early Feeding Practices in Screening for Impaired Glucose Tolerance and Undiagnosed Type 2 Diabetes. Source: Children's Hospital and Health System Foundation.
  • Family Genetic Study in Type 1 Diabetes Mellitus. Source: NIH-supported GCRC grant.
  • Feasibility of Continuous Subcutaneous Insulin Therapy in Toddler/Preschool Children with Type 1 Diabetes Mellitus. Source: Medtronic/MiniMed and Novo Nordisk Pharmaceuticals.                        

Contact information: 8701 Watertown Plank Road, Milwaukee, WI, 53226. Phone: (414) 266-6750. Fax: (414) 266-6749. E-mail: ralemzad@mcw.edu.

spacing image Arrow Back to top
spacing image page footer spacing image
spacing image
spacing image